The impact of border crossing and imprisonment on injection practices and risk of HIV and hepatitis C infection among men who inject drugs in Nepal

被引:0
|
作者
Zaccheo, Sonia K. [1 ,4 ]
Marrone, Gaetano [1 ]
Pandey, Lok Raj [2 ]
Deuba, Keshab [1 ,3 ]
机构
[1] Karolinska Inst, Dept Global Publ Hlth, SE-17177 Stockholm, Sweden
[2] Natl Ctr AIDS & STD Control NCASC, Minist Hlth & Populat, Kathmandu, Nepal
[3] Natl Ctr AIDS & STD Control NCASC, Global Fund Programs, Kathmandu, Nepal
[4] Georg August Univ, Univ Med Gottingen UMG, Fac Med, Gottingen, Germany
关键词
HIV; Hepatitis C virus; Injection drug use; Border crossing; Imprisonment; Risk behavior; PEOPLE; USERS; TRANSMISSION; PREVALENCE; HEALTH; VIRUS; CHINA; BIAS; INCARCERATION; BALTIMORE;
D O I
10.1016/j.drugpo.2023.104145
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Background: In Nepal, personal drug use is criminalized and among people who inject drugs (PWID), the majority of whom are men, movement across the border with India for drug procurement and use is common. Using a risk environment approach, this study examined associations between border crossing and imprisonment with respect to HIV, HCV and injection risk behavior among men who inject drugs in Nepal.Methods: This cross-sectional study analyzed data from 1345 participants from 14 districts across Nepal. Explanatory variables were prior imprisonment and past-month border crossing to procure or use drugs. We used multivariable logistic regression to evaluate associations between these variables and HIV, HCV, HIV/HCV co infection and past-month injection risk behavior among PWID. Results: Over half of participants reported prior imprisonment (34.6% prior to past year, 21.6% within past year) and Indo-Nepal border crossing in the past year to use or buy drugs (31.2% sometimes, 20.8% often); over one quarter of participants (29.6%) reported both. Imprisonment prior to the past year was associated with higher odds of all outcome variables: HIV (adjusted odds ratio (aOR) 2.44, 95% confidence interval (CI) 1.29-4.59), HCV (aOR 1.51, 95% CI 1.08-2.09), HIV/HCV co-infection (aOR 3.12, 95% CI 1.58-6.14) and injection risk behavior (aOR 1.64, 95% CI 1.20-2.25). Past-year border crossing to procure or use drugs was associated with HCV (aOR 2.06, 95% CI 1.42-2.98) and injection risk behavior (aOR 1.47, 95% CI 1.04-2.10), with larger effect sizes among PWID who reported both border crossing as well as history of imprisonment.Conclusion: Imprisonment and border crossing were associated with injection risk behavior and disease outcomes. These findings indicate a need to implement cross-border disease surveillance and harm reduction initiatives in the Indo-Nepal border region and in Nepali prisons.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] HIV and Hepatitis C Virus Infection and Risk Behaviors Among Heterosexual, Bisexual, and Lesbian Women Who Inject Drugs in Australia
    Iversen, Jenny
    Dolan, Kate
    Ezard, Nadine
    Maher, Lisa
    LGBT HEALTH, 2015, 2 (02) : 127 - 134
  • [42] HIV Prevalence, Estimated Incidence, and Risk Behaviors Among People Who Inject Drugs in Kenya
    Kurth, Ann E.
    Cleland, Charles M.
    Des Jarlais, Don C.
    Musyoki, Helgar
    Lizcano, John A.
    Chhun, Nok
    Cherutich, Peter
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2015, 70 (04) : 420 - 427
  • [43] Injection Partners, HCV, and HIV Status among Rural Persons Who Inject Drugs in Puerto Rico
    Habecker, Patrick
    Abadie, Roberto
    Welch-Lazoritz, Melissa
    Reyes, Juan Carlos
    Khan, Bilal
    Dombrowski, Kirk
    SUBSTANCE USE & MISUSE, 2018, 53 (07) : 1128 - 1138
  • [44] Injection drug use practices and HIV infection among people who inject drugs in Kigali, Rwanda: a cross-sectional study
    Jean Olivier Twahirwa Rwema
    Vianney Nizeyimana
    Neia M. Prata
    Nneoma E. Okonkwo
    Amelia A. Mazzei
    Sulemani Muhirwa
    Athanase Rukundo
    Lisa Lucas
    Audace Niyigena
    Jean Damascene Makuza
    Chris Beyrer
    Stefan D. Baral
    Aflodis Kagaba
    Harm Reduction Journal, 18
  • [45] Expanding access to prevention, care and treatment for hepatitis C virus infection among people who inject drugs
    Grebely, Jason
    Bruggmann, Philip
    Treloar, Carla
    Byrne, Jude
    Rhodes, Tim
    Dore, Gregory J.
    INTERNATIONAL JOURNAL OF DRUG POLICY, 2015, 26 (10) : 893 - 898
  • [46] Border Crossing to Inject Drugs in Mexico Among Injection Drug Users in San Diego, California
    Tyson Volkmann
    Sanghyuk S. Shin
    Richard S. Garfein
    Thomas L. Patterson
    Robin A. Pollini
    Karla D. Wagner
    Irina Artamanova
    Steffanie A. Strathdee
    Journal of Immigrant and Minority Health, 2012, 14 : 281 - 286
  • [47] Prevalence of HIV infection and associated risk behaviors among people who inject drugs in Kermanshah, Iran: 2017
    Etemad, Koorosh
    Sharhani, Asaad
    Higgs, Peter
    Gheibipour, Hamid
    JOURNAL OF SUBSTANCE USE, 2020, 25 (04) : 421 - 424
  • [48] Association of Self-Reported Abscess With High-Risk Injection-Related Behaviors Among Young Persons Who Inject Drugs
    Asher, Alice K.
    Zhong, Yuna
    Garfein, Richard S.
    Cuevas-Mota, Jazmine
    Teshale, Eyasu
    JANAC-JOURNAL OF THE ASSOCIATION OF NURSES IN AIDS CARE, 2019, 30 (02): : 142 - 150
  • [49] Egocentric network characteristics of people who inject drugs in the Chicago metro area and associations with hepatitis C virus and injection risk behavior
    Mackesy-Amiti, Mary Ellen
    Falk, Joshua
    Latkin, Carl
    Kaufmann, Maggie
    Williams, Leslie
    Boodram, Basmattee
    HARM REDUCTION JOURNAL, 2022, 19 (01)
  • [50] Spontaneous viral clearance of hepatitis C virus (HCV) infection among people who inject drugs (PWID) and HIV-positive men who have sex with men (HIV plus MSM): a systematic review and meta-analysis
    Smith, Daniel J.
    Jordan, Ashly E.
    Frank, Mayu
    Hagan, Holly
    BMC INFECTIOUS DISEASES, 2016, 16